A Randomised, Double-blind, Placebo Controlled, Parallel Group, Multi-centre, Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of ONO-4474 in Patients With Pain Due to Osteoarthritis of the Knee
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2017
At a glance
- Drugs ONO 4474 (Primary)
- Indications Osteoarthritis; Pain
- Focus Therapeutic Use
- Acronyms MOTION
- Sponsors Ono Pharmaceutical
- 24 Nov 2017 This trial was discontinued in Denmark, according to European Clinical Trials Database.
- 10 Apr 2017 Status changed from not yet recruiting to recruiting.
- 22 Dec 2016 New trial record